BIOL 201 – Chapter 16 Specific Defense: The Immune Response Study Notes

Adaptive (Specific) Immunity

  • Highly specialized, antigen-specific arm of host defense that develops after exposure to a particular pathogen or foreign molecule.

    • Distinguishing hallmarks:

    • Specificity: Each lymphocyte clone recognizes a single epitope; receptors generated by random gene rearrangement.

    • Diversity: >1011>10^{11} possible B-cell receptors (BCR) or T-cell receptors (TCR) can be produced, allowing recognition of virtually any organic molecule.

    • Clonal Expansion:

      • Upon first encounter with its cognate epitope, a naïve lymphocyte receives activation signals, enters rapid mitosis, and produces a large population of identical effector & memory cells.

      • Significance: amplifies a rare, antigen-specific cell into a force large enough to influence host physiology; accelerates response upon re-infection.

    • Memory: All adaptive responses leave behind long-lived memory B & T cells that survive in lymphoid tissues; these drive the much faster secondary immune response.

    • Self-tolerance: Autoreactive clones are deleted (central tolerance) or suppressed (peripheral tolerance) to minimize autoimmunity.

    • Two inter-linked arms:

    • Humoral Immunity: mediated by antibodies secreted from B-cell–derived plasma cells; best at neutralizing extracellular microbes/toxins.

    • Cell-Mediated Immunity: mediated by T lymphocytes (CD4, CD8) and NK cells; handles intracellular pathogens & tumor surveillance.

Lymphatic System & Lymphoid Organs

  • Structural Overview

    • Lymph: plasma-derived interstitial fluid that drains into lymphatic vessels; carries antigens, APCs, cytokines.

    • Lymphatic Vessels: thin-walled, blind-ended capillaries merge into progressively larger trunks that empty into the right lymphatic duct & thoracic duct → venous circulation.

    • Lymph Nodes: bean-shaped, encapsulated organs positioned along lymphatics; cortex rich in B-cell follicles, paracortex rich in T cells, medulla with plasma cells & macrophages.

    • Spleen: filters blood (not lymph); white pulp = lymphoid tissue around arterioles, red pulp = RBC recycling.

    • Thymus: site of T-cell maturation & clonal deletion; cortex densely packed with immature thymocytes, medulla with mature cells & Hassall’s corpuscles.

  • Mucosa-Associated Lymphoid Tissue (MALT)

    • Diffuse lymphoid aggregates monitoring mucosal surfaces (e.g., tonsils, adenoids, bronchial-, nasal- and genital-associated tissue).

    • Gut-Associated Lymphoid Tissue (GALT): specialized subset within intestines (Peyer’s patches, appendix, isolated lymphoid follicles).

    • Peyer’s Patches: domed lymphoid nodules in ileum; M cells sample intestinal lumen → deliver antigen to underlying dendritic cells.

  • Functional Themes: concentration of antigen, APCs, and lymphocytes in same microenvironment boosts likelihood of productive interactions.

Antigens & Antigen Presentation

  • Antigen: any molecule that can be bound by an antibody or TCR; immunogen if it elicits an immune response.

    • Epitopes (Antigenic Determinants): discrete 3-D regions recognized by lymphocyte receptors; proteins usually contain 10–2010–20 dominant epitopes.

    • Exogenous Antigens: originate outside host cells (bacteria, toxins), processed in endosomes → presented on MHC II.

    • Endogenous Antigens: synthesized within infected or neoplastic cells (viral proteins, mutated self proteins), processed by proteasome → presented on MHC I.

    • Autoantigens: self molecules capable of triggering disease when tolerance fails (e.g., insulin in Type I diabetes).

  • Antigen-Presenting Cells (APCs)

    • Professional APCs: dendritic cells, macrophages, B cells; constitutively express MHC II + costimulatory molecules (CD80/86).

    • Antigen Processing

    • MHC I Pathway: cytosolic proteins → ubiquitination → proteasome → peptide transport via TAP into ER → loaded onto MHC I → surface display → recognized by CD8 +^+ T cells.

    • MHC II Pathway: phagocytosed proteins → endosomal proteases → CLIP removal by HLA-DM → peptide-MHC II complex → surface → recognized by CD4 +^+ T cells.

    • Cross-Presentation: dendritic cells can load exogenous antigens onto MHC I, permitting CD8 activation against tumors/viruses that do not infect APCs directly.

B Lymphocytes & Antibodies (Humoral Response)

  • B-Cell Activation

    • T-Dependent Antigens (proteins): require CD4 +^+ T cell help; produce class switching, affinity maturation, memory.

    • T-Independent Antigens (polysaccharides, LPS): extensive cross-linking of BCRs; primarily IgM, little memory.

  • Antibody Structure

    • Two identical heavy (H) & light (L) chains linked by disulfide bonds.

    • Each chain has variable (V) & constant (C) domains; Fab region binds antigen, Fc region binds Fc receptors & complement.

    • Hinge gives flexibility; J chain links pentameric IgM & dimeric IgA.

  • Immunoglobulin Classes

    • IgM: pentamer; first made; excellent agglutinator; activates complement.

    • IgG: monomer; most abundant in serum; crosses placenta (passive immunity); opsonization & ADCC.

    • IgA: dimer in secretions (tears, milk, mucosa); key for MALT immunity.

    • IgE: binds FcεR on mast cells/basophils; mediates allergy & anti-helminth responses.

    • IgD: membrane receptor on naïve B cells; initiates activation.

  • Effector Mechanisms

    • Neutralization: antibodies block microbe attachment sites or toxin active sites.

    • Agglutination: cross-linking leads to clumping, enhancing phagocytosis.

    • Opsonization: Fc-mediated coating promotes phagocyte recognition; complement fragment C3bC_3b serves as additional opsonin.

    • Complement Activation: classical pathway begins when IgM or IgG Fc binds C1qC_1q.

  • Memory B Cells: long-lived, surface Ig with high affinity; rapidly differentiate into plasma cells upon re-exposure.

T Lymphocytes, NK Cells & Cell-Mediated Responses

  • Helper T Cells (CD4 +^+)

    • TH1: driven by IL-12; secrete IFN-γ, TNF-β; activate macrophages, support cytotoxicity, important vs. intracellular bacteria (e.g., Mycobacterium).

    • TH2: driven by IL-4; secrete IL-4, IL-5, IL-13; stimulate B-cell class switching to IgE/IgA, eosinophil activation, anti-helminth immunity.

    • Regulatory/Suppressor (Treg): express CD25 & FoxP3; produce IL-10, TGF-β to dampen immune reactions, enforce tolerance.

  • Cytotoxic T Cells (CD8 +^+)

    • Recognize MHC I–peptide complexes on infected or malignant cells.

    • Induce apoptosis via:

    • Perforin/Granzyme Pathway: perforin forms pores; granzymes enter cytosol → activate caspases → DNA fragmentation.

    • Fas–FasL Interaction: triggers death receptor pathway.

  • Natural Killer (NK) Cells

    • Innate-like lymphocytes lacking antigen-specific receptors.

    • Detect “missing self”: low MHC I expression → activation.

    • Use same perforin/granzyme arsenal; produce IFN-γ to shape TH1 bias.

Primary vs. Secondary Immune Responses

  • Primary Response

    • Lag phase ≈5–7\approx 5–7 days; IgM peaks first, followed by modest IgG.

    • Affinity of antibody relatively low; effector T cells peak and contract.

  • Secondary (Memory) Response

    • Lag phase ≤2\le 2 days; rapid, high-titer IgG (or IgA/IgE depending on prior class switching).

    • Higher affinity due to somatic hypermutation & selection.

    • Clinically correlated with milder or asymptomatic reinfection (basis of vaccination).

Types of Acquired Immunity

  • Naturally Acquired Active Immunity: infection → own immune response; durable memory.

  • Naturally Acquired Passive Immunity: maternal IgG across placenta & IgA in breast milk; immediate but temporary (∼6\sim 6 months).

  • Artificially Acquired Active Immunity: vaccination (e.g., whole-cell killed vaccine); induces primary response without disease.

  • Artificially Acquired Passive Immunity: injection of preformed antibodies/antitoxins (e.g., rabies Ig, anti-venom); rapid, short-lived.

Glossary of Key Terms (Alphabetical)

  • Agglutination: antibody-mediated clumping of particles; enhances clearance.

  • Apoptosis: programmed cell death involving caspase cascade & membrane blebbing; minimizes inflammation.

  • Autoantigen: self antigen that can trigger autoimmunity when tolerance fails.

  • Chemokines: chemotactic cytokines directing cell migration (e.g., CXCL8).

  • Clonal Deletion: elimination of self-reactive lymphocytes during development (central tolerance).

  • Clonal Selection: activation & proliferation of lymphocytes whose receptors bind a specific antigen.

  • Cytokines: soluble proteins (interleukins, interferons, TNFs) that mediate cell communication.

  • Endogenous/Exogenous Antigen: generated within vs. outside host cells.

  • Fc Region: constant region of antibody heavy chain; engages Fc receptors & complement.

  • Granzyme: serine protease from CTL/NK granules inducing apoptosis.

  • Growth Factors: cytokines that drive cell proliferation (e.g., IL-2 for T cells).

  • Immunity: state of protection against infectious disease.

  • Interferons (IFNs): antiviral cytokines (Type I IFN-α/β, Type II IFN-γ).

  • Interleukins (IL): cytokines acting between leukocytes.

  • Lymph: fluid in lymphatic system.

  • Lymphocytes: B, T, NK cells; key for adaptive & innate immunity.

  • Macrophages: phagocytes derived from monocytes; APCs; secrete cytokines.

  • Major Histocompatibility Complex (MHC): polymorphic loci coding for antigen-presenting molecules; termed HLA in humans.

  • Memory Responses: heightened, rapid responses upon re-exposure.

  • Natural Killer Cells (NK): innate lymphocytes killing virus-infected/tumor cells without prior sensitization.

  • Neutralization: antibody prevents pathogen/toxin interaction with host targets.

  • Opsonization: coating that enhances phagocytosis via Fc or complement receptors.

  • Perforins: pore-forming proteins secreted by CTL/NK cells.

  • Plasma Cells: terminally differentiated B cells secreting large quantities of antibodies.

  • Primary/Secondary Immune Response: first vs. subsequent encounters with same antigen.

  • Suppressor T Cells (Treg): inhibit immune responses to maintain tolerance.

  • T-Cell Receptor (TCR): heterodimeric protein (αβ or γδ) recognizing peptide–MHC.

  • Tumor Necrosis Factors (TNF): cytokines mediating inflammation & apoptosis; TNF-α key in septic shock.

Practical & Ethical Implications

  • Vaccination campaigns exploit memory responses to confer herd immunity; ethical debates revolve around mandates vs. autonomy.

  • Understanding clonal deletion informs therapies for autoimmunity (e.g., inducing tolerance in type 1 diabetes).

  • NK- and T-cell cytotoxic mechanisms are harnessed in cancer immunotherapy (CAR-T, checkpoint blockade).